| The PI3K/Akt pathway in tumors of endocrine tissues HL Robbins, A Hague Frontiers in endocrinology 6, 188, 2016 | 146 | 2016 |
| A state-of-the-art review of stratified medicine in cancer: towards a future precision medicine strategy in cancer G Middleton, H Robbins, F Andre, C Swanton Annals of Oncology 33 (2), 143-157, 2022 | 42 | 2022 |
| Supplementation of vitamin D deficiency in patients with neuroendocrine tumors using over-the-counter vitamin D3 preparations HL Robbins, M Symington, B Mosterman, J Goodby, L Davies, ... Nutrition and cancer 70 (5), 748-754, 2018 | 24 | 2018 |
| Machine learning for determining lateral flow device results for testing of SARS-CoV-2 infection in asymptomatic populations AD Beggs, CCS Caiado, M Branigan, P Lewis-Borman, N Patel, T Fowler, ... Cell Reports Medicine 3 (10), 2022 | 11 | 2022 |
| The PI3K/Akt pathway in tumors of endocrine tissues. Front Endocrinol (Lausanne). 2016; 6: 188 HL Robbins, A Hague | 6 | 2015 |
| Interferon gamma release assay in the diagnosis of tuberculous mastitis HL Robbins, M Hetzel, S Mungall, SJ Cawthorn The Annals of The Royal College of Surgeons of England 97 (1), e1-e2, 2015 | 5 | 2015 |
| Fertility preservation in young cancer patients—too little, too late? HL Robbins, A Zahoor, K Jones Supportive Care in Cancer 23, 3395-3397, 2015 | 4 | 2015 |
| MHC class II is induced by IFNγ and follows three distinct patterns of expression in colorectal cancer organoids OJ Pickles, K Wanigasooriya, A Ptasinska, AJ Patel, HL Robbins, C Bryer, ... Cancer Research Communications 3 (8), 1501-1513, 2023 | 2 | 2023 |
| Effects of intake of breakfast or caffeine‐containing beverages on measurement of circulating chromogranin A in plasma HL Robbins, M Symington, B Mosterman, F Tranter, L Davies, ... GastroHep 1 (1), 11-21, 2019 | 2 | 2019 |
| Machine learning for determining lateral flow device results in asymptomatic population: a diagnostic accuracy study R Banathy, M Branigan, P Lewis-Borman, N Patel, L Lee, TA Fowler, ... | 1 | 2021 |
| Akt as a potential prognostic marker in neuroendocrine tumors: a possibility? A Hague, HL Robbins International Journal of Endocrine Oncology 3 (4), 281-284, 2016 | 1 | 2016 |
| The potential clinical utility of Whole Genome Sequencing for patients with cancer: evaluation of a regional implementation of the 100,000 Genomes Project EYL Leung, HL Robbins, S Zaman, N Lal, D Morton, L Dew, AP Williams, ... British Journal of Cancer, 1-9, 2024 | | 2024 |
| PR070/# 754 The potential clinical utility of whole genome sequencing for patients with gynaecological cancer: the 100,000 genomes project regional implementation E Leung, H Robbins, S Zaman, N Lal, D Morton, L Dew, A Williams, ... International Journal of Gynecologic Cancer 34 (Suppl 3), 2024 | | 2024 |
| 1204P Real-world utility of whole genome sequencing for patients with cancer: Evaluation of a regional implementation of the 100,000 genomes project HL Robbins, E Leung, S Zaman, N Lal, D Morton, L Dew, A Williams, ... Annals of Oncology 35, S773, 2024 | | 2024 |
| Abstract A115: mTOR targeting in STK11 deficient Non-Small Cell Lung Cancer (NSCLC): final results, pre-clinical rationale and biomarker analysis of a phase II trial of the … HL Robbins, P Fletcher, J Savage, M Mehmi, Y Summers, A Greystoke, ... Molecular Cancer Therapeutics 22 (12_Supplement), A115-A115, 2023 | | 2023 |
| mTOR targeting in STK11 deficient Non-Small Cell Lung Cancer (NSCLC): final results, pre-clinical rationale and biomarker analysis of a phase II trial of the mTORC1/2 inhibitor … HL Robbins, P Fletcher, J Savage, M Mehmi, Y Summers, A Greystoke, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| Major histocompatibility complex-class II is induced by Interferon-gamma and follows three distinct patterns of expression in colorectal cancer organoids OJ Pickles, K Wanigasooriya, A Ptasinska, AJ Patel, H Robbins, P Taniere, ... Cancer Research Communications, CRC-23-0091, 2023 | | 2023 |
| Colorectal cancer displays three patterns of tumor-specific MHC-II inducibility and dynamics, with implications for combining epigenetic therapy with immunotherapy OJ Pickles, K Wanigasooriya, A Ptasinska, AJ Patel, HL Robbins, C Bryer, ... Cancer Research 83 (7_Supplement), 2989-2989, 2023 | | 2023 |
| Supplementation of vitamin D deficiency/insufficiency in patients with GEP-NET using over the counter vitamin D3 preparations HL Robbins, M Symington, B Mosterman, J Goodby, GK Dimitriadis, ... Endocrine Abstracts 52, 2017 | | 2017 |
